Big Rock Partners Acquisition Corp. (NASDAQ:BRPA) filed an 8-K this afternoon showing that its shareholders had approved extending its transaction deadline to April 23, 2021.
Additionally, Big Rock tallied zero redemptions in connection with the move, despite what would normally be an attractive redemption rate of $10.78.
Four days ago, Big Rock announced a definitive combination agreement with NeuroRx. It is a biopharmaceutical firm working to secure regulatory approval for a potential COVID-19 therapy that could increase recovery times from respiratory failure.
This news pushed the company’s stock up to $13.79 on the morning of its redemption deadline and it opened today at $15.70. However, being fairly “low-float” might have been a contributing factor.
Big Rock initially listed in November 2017, and as such has had to extend its deadline five times before, resulting in 92% of its original shares redeeming. It has structured its deal with NeuroRx with an incentive structure strongly tied to it crossing regulatory benchmarks with its COVID-19 treatment.
For a full description of measures on the ballot and vote tallies, click HERE.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...